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ABSTRACT
Objective: To identify the available evidence in the literature on health-related quality of life in adults with sickle cell disease. 
Method: integrative review of MEDLINE, CUMED, LILACS and SciELO databases, from articles developed in this area, published 
between 2005 and 2015, in English, Portuguese or Spanish. Results: 22 articles were included, six scales were used to evaluate 
health-related quality of life scores: three generic and three specifi c. No specifi c scale for adults with sickle cell disease has 
been adapted to Brazilian Portuguese so far. Patients affected by frequent painful crises, with low adherence to treatment, had 
a compromised quality of life. Conclusion: Selected studies have shown that patients with sickle cell disease have worse scores 
than the general population. These indicators should be instrumental to the nurse in the proposal of interventions and strategies 
of assistance and socio-educational, with a view to improving the quality of life of this clientele.
Descriptors: Quality of Life; Sickle Hemoglobin; Inquiries and Questionnaires; Nursing; Based on Evidence.
RESUMO
Objetivo: Identifi car as evidências disponíveis na literatura sobre qualidade de vida relacionada à saúde em adultos com doença 
falciforme. Método: revisão integrativa nas bases de dados MEDLINE, CUMED, LILACS e SciELO, de artigos provenientes de estudos 
desenvolvidos nesta temática, publicados entre 2005 a 2015, em inglês, português ou espanhol. Resultados: foram incluídos 22 
artigos, sendo utilizadas seis escalas para avaliar os escores de qualidade de vida relacionada à saúde: três genéricas e três específi cas. 
Nenhuma escala específi ca para adultos com doença falciforme foi adaptada para o português brasileiro até o momento. Pacientes 
acometidos por crises dolorosas frequentes, com baixa adesão ao tratamento, apresentaram comprometimento da qualidade de vida. 
Conclusão: Os estudos selecionados evidenciaram que os pacientes com doença falciforme têm piores escores do que a população 
em geral. Esses indicadores deveriam instrumentalizar o enfermeiro na proposição de intervenções e estratégias assistenciais e 
socioeducativas, com vistas a melhorar a qualidade de vida desta clientela.
Descritores: Qualidade de Vida; Hemoglobina Falciforme; Inquéritos e Questionários; Enfermagem; Baseada em Evidência.
RESUMEN
Objetivo: Identifi car las evidencias disponibles en la literatura sobre cualidad de vida relacionada a la salud en adultos con enfermedad 
falciforme. Método: revisión integradora en las bases de datos MEDLINE,CUMED,LILACS y SciELO, de artículos provenientes de 
estudios desarrollados en  esta temática, publicados entre 2005 y 2015, en inglés, portugués o español. Resultados: fueron incluidos 
22 artículos, siendo utilizadas seis escalas para evaluar las puntuaciones de cualidad de vida relacionada a la  salud: tres genéricas y 
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INTRODUCTION
The term sickle cell disease (DF) is used to denote a group 
of genetic disorders in which there is a predominant hemo-
globin (Hb) variant called HbS, which originates from a point 
mutation resulting in the substitution of glutamic acid by va-
line at position 6 of the β-globin(1). The most frequent forms 
of FD are: sickle cell anemia, homozygous and more severe 
form (HbSS); HbS hemoglobinopathy in association with an-
other Hb variant (HbC) and Sb - thalassemia (Sb - tal), which 
presents the HbSβ - tal or HbSβ +-tal subtypes(2).
This mutation produces changes in the structure of HbS 
that, under conditions of low oxygen concentration, undergoes 
polymerization. These polymer chains inside the erythrocytes 
cause a change in their shape, loss of characteristic deformabil-
ity, acquiring the shape of sickle (falcization). Sickle red cells 
cause vaso-occlusion and trigger inflammatory process, with 
consequent tissue damage. Patients usually present several com-
plications, which begin in childhood, as a result of repeated 
vaso-occlusive episodes, chronic inflammation and hemolysis(3).
Characterized by severe musculoskeletal pain and chronic 
hemolytic anemia, FD can present several complications, in-
cluding: infections, heart disease, renal failure, stroke, leg ul-
cers and proliferative retinopathy(2-5).
In addition to pain and suffering, this disease can lead to 
decreased coping ability and difficulty for these people to be-
come productive citizens, which impacts the life of the patient 
and reduces their quality of life (QoL)(5). Understanding the 
perception of the individual with chronic disease on his QOL 
makes it possible to know the necessary adjustment processes 
in the face of the chronicity of the disease and to create subsi-
dies that support the interventions of the health professionals.
The World Health Organization(6) defines QOL as ‘the in-
dividual’s perception of their position in life in the context of 
the culture and value system in which they live and in rela-
tion to their goals, expectations, standards and their interests’. 
This term has been used by the population in general, but has 
stimulated countless studies developed by professionals who 
provide assistance to people affected by various diseases.
The term health-related quality of life (HRQoL), in addition 
to describing the QoL of a specific population, also examines 
the impact of diseases or health interventions on QoL, and 
has arisen with increased survival and prevalence of chronic 
diseases(7). The QV is evaluated through instruments, consist-
ing of different numbers of items (or questions) grouped into 
domains or areas. They are formulated mostly in the Eng-
lish language and directed to the population that uses that 
language, and should be translated into other languages  when 
necessary, always following strictly the norms of the literature 
pre-established for their translation(8). 
These instruments, also called scales or questionnaires, 
may be generic or specific. As an advantage, generic scales 
can be applied to any population and, therefore, allow com-
parison between people with different diseases. The specifics 
are more sensitive, since they are designed to evaluate the 
QoL of individuals belonging to specific populations (chil-
dren, adults, men, women, elderly) or with certain diseases 
(cancer, diabetes, rheumatoid arthritis)(9).
Given the importance of knowing how adults with DF 
evaluate their QOL, this integrative review of the literature 
was proposed with the objective of identifying the evidence 
on HRQoL in this disease. 
METHOD
Study design
It is a descriptive study that used the integrative review be-
cause it is one of the resources of the Evidence-Based Practice 
that enables the researcher to analyze and synthesize the sci-
entific knowledge about the object of the study, through the 
results of previous research, as well as to identify gaps that 
must be fulfilled through further investigation(10). 
Methodological reference and the respective steps
During the development of this integrative review, the six 
stages were rigorously covered: 1) Identification of the theme 
and selection of the hypothesis or the guiding question of re-
search; 2) Establishment of criteria for inclusion and exclusion 
of studies, sampling and search in the literature; 3) Data col-
lection and categorization of studies; 4) Critical analysis of 
included studies; 5) Discussion of the results and 6) Synthesis 
and presentation of the review (Figure 1)(11). 
A broad guiding question was adopted for this study: 
what evidence is available in the literature about HRQoL as-
sessment in adults with FD, which scales were used, and of 
which, which have already been validated in Brazil? The bib-
liographic survey was carried out from August 2015 to January 
2016, in the electronic databases MEDLINE (Medical Litera-
ture Analysis and Retrieval System Online), CUMED (National 
Center of Information of Medical Sciences of Cuba), LILACS 
(Latin American Literature and the Caribbean in Health Sci-
ences) and SciELO (Scientific Electronic Library Online). The 
first three were accessed by the Virtual Health Library (BVS / 
BIREME) operating platform.
Sandra Luzinete Felix de Freitas      E-mail: sandra.freitas@ufms.brCORRESPONDING AUTHOR
tres específicas. Ninguna escala específica para adultos con enfermedad falciforme fue adaptada para el portugués brasileño hasta el 
momento. Pacientes acometidos por crisis dolorosas frecuentes, con baja adhesión al tratamiento, presentaron comprometimiento 
de la cualidad de vida. Conclusión: Los estudios seleccionados evidenciaron que los pacientes con enfermedad falciforme tienen 
peores puntuaciones  que la población en general. Esos indicadores deberían instrumentalizar el enfermero en la proposición de 
intervenciones y estrategias asistenciales y socioeducativas, con vistas a mejorar la cualidad de vida de esta clientela.
Descriptores: Cualidad de Vida; Hemoglobina Falciforme; Investigaciones  y Cuestionarios; Enfermería; Basada en Evidencia.
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To search the databases, we used some controlled descrip-
tors (quality of life, sickle cell disease and questionnaires); key-
words that do not appear as controlled descriptors in Health 
Sciences Descriptors (health related quality of life, instrument 
and scale) and Boolean operators (AND / OR), in different as-
sociations among themselves, in the English, Portuguese and 
Spanish languages. There was a need to use keywords, since 
not all the terms that represent the subject to be studied were 
registered in the website Descriptors in Health Sciences. 
Inclusion criteria were: original articles from studies whose 
objective was to evaluate QoL in adults with FD, published 
in the period 2005 to 2015, with abstracts available and that 
could be accessed in full by the online medium in English, 
Portuguese or Spanish.
In order to avoid bias in the selection of articles, during the 
search and selection phase, two researchers acted indepen-
dently(10). After selecting the articles, a data collection instru-
ment was developed by the main author to synthesize each 
study selected in the space of a page, with relevant content, 
containing the following information: article identification (ti-
tle, periodical, descriptors, base data, authors, country where 
it was developed, year and language of publication); Method-
ological characteristics (type of study, level of evidence, sam-
ple characterization and scale of evaluation of HRQoL used), 
objective, results and conclusion. 
After analyzing each article, the reviewers organized and 
synthesized the information, creating an Excel® database that 
was easy to access and manipulate. 
RESULTS
Figure 2 illustrates the process of capturing articles in the 
MEDLINE, CUMED, LILACS and SciELO databases, accord-
ing to the associations of keywords and / or descriptors; the 
number of articles selected and excluded according to the in-
clusion criteria; language of publication; design and level of 
evidence of the studies.
The search in the databases, with the four associations of key-
words, resulted in a total of 802 publications, being 521 (64.9%) 
in English, 253 (31.5%) in Portuguese and 28 (3.5 %) in Span-
ish. After submission to the inclusion criteria, 22 articles were 
selected (Figure 2). 
Figure 1 – Stages of integrative literature review
- Define the focus of the research, the guiding hypothesis or question, 
the descriptors or keywords, and the research objectives.
- It is equivalent to data analysis in conventional research;
- Analyze critically and impartially, explaining the different or 
conflicting results in different studies.
- Establish criteria for inclusion and 
exclusion of studies;
- Select features for search: 
database, manual search in 
journals, etc;
- Perform the search in the selected 
databases;
- Use descriptors or keywords in 
the search.
- Extract, organize and 
summarize information;
- Use an instrument to 
collect and synthesize key 
information;
- To evaluate the level of 
evidence of the studies;
- Build the database.
- Elaborate the document that 
describes the steps taken by 
the reviewer, the available 
evidence in the literature 
on the topic researched, the 
main results from the analysis 
of the included articles and 
the synthesis and conclusion 
of the information.
- This stage is equivalent to 
the discussion of results in 
conventional research;
- Make the comparison with 
the theoretical knowledge, 
conclusions and implications 
that resulted from the integrative 
review;
- Identify factors that affect the 
research theme;
- To point out gaps in knowledge;
- Suggests future research.
Integrative 
literature 
review
1st STEP
Choice of 
theme
2nd STEP
Sampling and 
literature search
5th STEP
Interpretation 
of results
6th STEP
Synthesis of 
knowledge
3rd STEP
Data collect
4th STEP
Critical evaluation 
of selected studies
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It was observed that, al-
though the studies were very 
well delineated(12), 13 (59.1%) 
were level VI (12 cross-sec-
tional studies and one quali-
tative study), eight (36.4%) 
level IV articles two cohort 
studies and four case-control 
studies) and one (4.5%) level 
II (clinical, randomized, dou-
ble-blind, controlled trial).
In Chart 1 it is possible to 
visualize the distribution of 
the 22 articles analyzed, ac-
cording to authors, periodi-
cal, periodical classification, 
year of publication, country 
where it was developed, scale 
of evaluation of HRQoL used 
by the researchers, objec-
tives, delineation and level 
of evidence of each study , in 
addition to the database.
Regarding the geographic 
distribution, eight (36.4%) 
studies were developed in 
Brazil, six (27.3%) in the Unit-
ed States of America (USA), 
three (13.6%) in Jamaica, 
two (9.1%) in Saudi Arabia, 
two (9.1%) in Cuba and one 
(4.5%) in the Netherlands. 
After analyzing and syn-
thesizing the articles selected 
for this review, in order to fa-
cilitate reading and compre-
hension, we chose to group 
the results and discussion 
into three categories: Socio-
demographic aspects and 
genotypes of the participants 
of the selected studies; Scales 
used to assess health-related 
quality of life; and Quality of 
life of patients with sickle cell 
disease.
Chart 1 – Articles selected according to the associations of controlled descriptors and / or keywords used, authors, title, peri-
odicals, year of publication, country where it was developed and database
Base Author, title of article Periodic, classification, year and country Scale Objectives
Design and level 
of evidence
M
ED
LI
N
E
McClish et al(13). Health related 
quality of life in sickle cell patients: 
the PiSCES project.
Health Qual Life 
Outcomes (B1), 2005, 
USA S
F3
6
To evaluate the QOL of patients 
with DF participating in The Pain 
in Sickle Cell Epidemiology Study 
(PiSCES)
Cohort - groups: 
asthma, cystic fibrosis 
and dialysis.
Level IV
To be continued
Research conducted from August 2015 to January 2016
Found 802 publications
Inclusion criteria
MEDLINE (n=589) MEDLINE (n=589) MEDLINE (n=589) MEDLINE (n=589)
Keyword associations (in English, Portuguese and Spanish) and Boolean operators used:
Guiding question: what are the available evidence in the literature on the evaluation of HRQoL 
in adults with FD, which scales were used and, of these, which have already been validated in Brazil?
(A) Health-related quality 
of life AND sickle cell 
disease OR questionnaire 
OR instrument OR scale 
(n=63)
(B) Health-related quality 
of life AND sickle cell 
disease (n=55)
(C) Sickle cell disease 
AND quality of life AND 
instrument (n=22)
(D) Sickle cell disease 
AND quality of life 
(n=662)
articles from studies on 
QOL assessment in adults 
with DF
published in the period 
2005 to 2015, in English, 
Portuguese or Spanish
with abstracts available
accessed in full by the 
online medium
MEDLINE (n=13)
Deleted 
articles 
(n=780)
LILACS (n=7)
SCIELO (n=1)
CUMED (n=1)
Selected studies (n=22)
Design of studies: 
ttransversal (n=12), 
cohort (n=4), 
case-control (n=4), 
clinical trial (n=1), 
qualitative (n=1)
Language: 
English (n=18), 
Spanish (n=2) and 
Portuguese (n=2)
other publication period 
(n=75)
not available in full 
(n=l38)
another object of study 
(n=4 71)
another language 
(n=3)
repeated  
(n=93)
Note: QRS (Health-Related Quality of Life), MEDLINE (Medical Literature Analysis and Retrieval System Online), 
LILACS (Latin American and Caribbean Literature in Health Sciences), SciELO (Scientific Electronic Library Online) and 
CUMED of Medical Sciences of Cuba)
Figure 2 – Flowchart of the abstraction of selected articles in the MEDLINE, CUMED, LI-
LACS and SciELO databases, according to inclusion criteria, Campo Grande, 
Mato Grosso do Sul, Brazil, 2016
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Base Author, title of article Periodic, classification, year and country Scale Objectives
Design and level 
of evidence
M
ED
LI
N
E
Ballas et al(14). Hydroxyurea and 
sickle cell anemia: effect on quality 
of life.
Health Qual Life 
Outcomes (B1), 2006, 
USA S
F3
6 To evaluate the effect of hydroxyurea 
(HU) on the quality of life of patients 
with sickle cell anemia (AF)
Clinical, double-blind, 
randomized trial
Level II
Asnani et al (4). Component structure 
of the SF-36 in Jamaicans with sickle 
cell disease.
West Indian Med J 
(B1), 2007, Jamaica SF
36
To evaluate the structural 
component of SF36 in Jamaican 
patients with DF
Randomized cohort, 
random sample
Level IV
Adams-Graves et al(5). Development 
and validation of SIMS: an instrument 
for measuring quality of life of adults 
with sickle cell disease.
Am J Hematol (A1)
2008 USA SI
M
S
To develop the Sickle Disease 
Impact Measurement Scale (SIMS), 
an instrument to measure the 
quality of life of adults with DF
Case control - creation 
and testing of scale 
with two groups.
Level IV
Asnani et al(1). Quality of life in 
patients with sickle cell disease in 
Jamaica: rural-urban differences.
Rural Remote Health
2008 Jamaica SF
-3
6 To know the differences between 
the QOL of patients with FD who 
live in urban and rural areas
Analytical 
observational Level IV
Asnani et al(15). Utility of WHOQOL-
BREF in measuring quality of life in 
sickle cell disease.
Health Qual Life 
Outcomes
2009 Jamaica
W
H
O
Q
O
L 
Br
ef
To study the usefulness of 
WHOQOL-Bref in the QOL 
measurement of patients with DF
Control case
Level IV
van Tuijn et al(16). Pain rate and 
social circumstances rather 
than cumulative organ damage 
determine the quality of life in 
adults with sickle cell disease
Am J Hematol (A1), 
2010, Netherlands
SF
36
To evaluate prospectively (5 years) 
QoL in a cohort of patients with 
FD, related to chronic organ 
damage, pain rate and history of 
complications related to the disease
Cohort Level IV
Dampier et al(17). Health-related 
quality of life in adults with sickle 
cell disease (SCD): a report from 
the comprehensive sickle cell 
centers clinical trial consortium.
Am J Hematol (A1), 
2011, USA
SF
36
To examine the relationship 
between the various 
complications related to FD and 
quality of life (QoL)
Cohort Level IV
Anie et al(18). Patient self-assessment of 
hospital pain, mood and health-related 
quality of life in adults with SCD
BMJ Open (B1), 2012, 
USA EQ
-5
D Characterize the relationship of pain with mood and QOL at 
admission, before discharge and at 
one post-discharge week
Transversal Level VI
Ohara et al(19). Musculoskeletal 
pain, profile and quality of life of 
individuals with SCD.
Rev. bras. Fisioter (B1)
2012 Brazil
W
H
O
Q
O
L 
B
re
ef
To verify the relationship between 
musculoskeletal pain, considering 
its body location, social, economic 
and QoL characteristics in 
individuals with DF
Transversal Level VI
Al Jaouni et al(20). Treatment 
adherence and quality of life 
outcomes in patients with SDC
Saudi Med J (B3), 
2013, Saudi Arabia 
W
H
O
Q
O
L 
B
re
ef
To evaluate the HRQOL of patients 
with FD and to measure the impact 
of adherence to treatment on 
the complications of the disease, 
severity, crises, and outcomes
Transversal Level VI
Keller et al(7). Patient reports of health 
outcome for adults living with sickle 
cell disease: development and testing 
of the ASCQ-Me item banks.
Health Qual Life 
Outcomes (B1), 2014, 
USA A
SC
Q
-
M
e Develop Adult Sickle Cell Quality of Life Measurement System 
(ASCQ-Me)
Transversal Level VI
Ahmed et al(21). Health Qual Life 
Outcomes Health- related quality of 
life in patients with sickle cell disease 
in Saudi Arabia.
Health Qual Life 
Outcomes (B1), 2015. 
Saudi Arabia S
F3
6 Describe the characteristics of 
Saudi patients with FD and their 
impact on QoL
Transversal Level VI
LI
LA
C
S
Pereira et al(22). Sickle cell disease 
and quality of life: a study on the 
subjective perception of patients from 
the Fundação Hemominas, Minas 
Gerais, Brasil.
Rev. bras. Hematol 
Hemoter (B3), 2008, 
Brazil
W
H
O
Q
O
L 
B
re
ef
To investigate whether the concept 
of QoL advocated by the World 
Health Organization (WHO) could 
be used for patients with DF
Qualitative VI
Chart 1
To be continued
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Base Author, title of article Periodic, classification, year and country Scale Objectives
Design and level 
of evidence
LI
LA
C
S
Roberti et al(3). Avaliação da 
qualidade de vida em portadores 
de doença falciforme do Hospital 
das Clínicas de Goiás, Brasil.
Rev. bras. Hematol 
Hemoter (B3), 2010, 
Brazil
W
H
O
Q
O
L 
B
re
ef
 To evaluate the QOL of patients 
with sickle cell disease treated 
at Hospital das Clínicas, 
Universidade de Goiás
Transversal Level VI
Santos et al(23). Sociodemographic 
aspects and quality of life of patients 
with SCA.
Rev. bras. Hematol 
Hemoter (B3), 2013, 
Brazil S
F3
6 To describe the sociodemographic 
profile and the impact of the disease 
on the QOL of patients with AF
Transversal Level VI
Losilla et al(24). Evaluating quality 
of life in patients with sickle cell 
disease: Differences between adults 
and children.
Medicina (RP) (B4), 
2013, Brazil
W
H
O
Q
O
L 
B
re
ef
To describe and analyze the QoL 
of patients with sickle cell anemia 
at a hematology clinic of a school 
hospital in the Southeast Region, 
Brazil
Transversal Level VI
Pereira et al(25). Sickle Cell Disease: 
quality of life in patients with 
hemoglobin SS and SC disorders.
Rev. bras. Hematol 
Hemoter (B3), 2013, 
Brazil
W
H
O
Q
O
L 
Br
ee
f To evaluate the QoL of 
patients with DF (HbSS and 
HbSC) and their clinical and 
sociodemographic characteristics
Transversal Level VI
Mastandréa et al(26). The 
relationship between genotype, 
psychiatric symptoms and quality 
of life in adult patients with sickle 
cell disease in São Paulo, Brazil: a 
cross-sectional study.
São Paulo Med J (B2), 
2015, Brazil SF
36
To describe the psychiatric 
symptomatology present in the 
Brazilian patient with sickle 
cell disease and to evaluate the 
relationship of these symptoms 
with the genotype of the disease 
and the subject’s HRQL
Transversal Level VI
Martínez-Triana et al(27). Efecto de 
la drepanocitosis sobre la calidad 
de vida.
Rev. cuba Hematol, 
Inmunol Hemoter (SI), 
2015, Cuba S
F3
6
To determine the HRQoL of adult 
patients with DF who receive care 
at the Institute of Hematology and 
Immunology (IHI)
Control case IV
C
U
M
ED
Martínez-Triana et al(2). Cuestionario 
para evaluar la calidad de vida 
relacionada con la salud de adultos 
con drepanocitosis.
Rev. cuba Hematol, 
Inmunol  Hemoter (SI), 
2012, Cuba C
EB
-S
Development and validation of a 
specific questionnaire to evaluate 
the QOL of patients with DF 
(CEB-S)
Control case Level IV
SC
IE
LO
Vilela et al(28). Quality of life of 
individuals with sickle cell disease 
followed at referral centers in 
Alagoas, Brasil.
Rev. bras. Hematol 
Hemoter (B3), 2012, 
Brazil S
F3
6 To evaluate the HRQoL of 
individuals with FD followed at 
reference centers in Alagoas, Brazil
Transversal Level VI
Note: MEDLINE, LILACS, CUMED, SCIELO, SF36 (Medical Outcome Study 36 item Short Form), SIMS (Sickle Cell Impact Measuring Scale), WHOQOL Breef (World 
Health Organization Quality of Life Assessment Instrument Bref), EQ-5D (EuroQol), ASCQ-Me (Adult Sickle Cell Quality of Life Measurement System), CEB-S (Cues-
tionario específico sobre calidad de vida en drepanocitosis).
Chart 1 (concluded)
Socio-demographic and genotype aspects of study par-
ticipants
Among the 22 articles selected, the majority of the partici-
pants were: women in 21 (95.5%)(1-5,7,13-18,20-28), with HbSS / Sβº 
Tal genotypes in 19 (86.4%)(1-2,4-5,7,13-17,19-20,22-28); unmarried chil-
dren in 13 (59.1%)(1,3-5,13,15,20-27) and low schooling 12 (54.5%)
(3,5,13,15-16,20-25,28).  
Scales used to assess health-related quality of life 
This review demonstrated that six HRQoL assessment 
scales were used, three generic and three specific. The ge-
neric ones were: Medical Outcome Study 36 item Short 
Form - SF36 (n = 11)(1,4,13-14,16-17,21,23,26-28); World Health 
Organization Quality of Life Assessment Instrument Bref - 
WHOQOL-Bref (n = 7)(3,15,19-20,22,24-25) and EuroQol EQ-5D 
(n = 1)(18).
Three articles described the development of specific scales 
to evaluate the HRQoL of adults with FD: specific question-
naire on quality of life in sickle cell disease - CEB-S(2), Sickle 
Cell Impact Measurement Scale (SIMS) and Adult Sickle Cell 
Quality of Life Measurement System - ASCQ-Me (7). 
Quality of life of patients with sickle cell disease
Patients with FD had QOL (n = 6)(3,12,14,23,26,28), HRQoL worse 
than the general population (n = 3)(13,14,27), work (n = 3)(22-23,25) and 
low-paid jobs (n = 1)(23).
One study showed that symptoms of depression were present 
in 30% of participants, anxiety symptoms in 12.7% and alcohol 
abuse in 9.1%(26). It was also possible to verify that pain(13,15-19,25,28) 
and psychological distress(18) contributed to reduce the HRQoL 
scores, and their score was significantly reduced when pain levels 
increased(13). 
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DISCUSSION
The present study proved that the integrative literature re-
view is capable of systematically, orderly and synthesized the 
results of researches, which contributes to increase knowledge 
about HRQoL in people with FD.
Due to the technological advances in the area of  health, 
there was an increase in the survival of the people and, conse-
quently, also the prevalence of chronic-degenerative diseases 
and their sequels increased.
The increase in life expectancy has resulted in an increase 
in the number of people with chronic diseases, that is, those 
that are not curable(29). In these cases, the goal of care no lon-
ger resides simply in healing, and now includes promoting 
improvements in the lives of these patients. In recent decades, 
the international scientific community has been increasingly 
interested in studying the concept of QOL, a fact observed in 
this review study, in which it was possible to verify that the 
concern with the QoL of people with FD is increasing, since 
the majority (63.6%) of the articles selected for this study was 
published between the years 2010 and 2015.
Studies have shown that patients diagnosed with chronic dis-
eases have a higher risk of developing stress, anxiety and de-
pression, as well as the consequent impairment of their QoL 
index(30), whose evaluation provides pertinent information that 
supports the planning of effective actions for such patients(31).
It was verified that evaluation of the patient’s QoL is recog-
nized as an important area of  scientific knowledge, since the 
instruments used to evaluate the patient’s perception regard-
ing their HRQOL are multidimensional, measuring changes in 
the physical, functional, psychological and social aspects , as 
well as self-assessment of their state of health.
Of the four keyword associations used in this review, three 
(A, C, and D) provided results and the majority (86.4%) of 
the articles had been published in English. Using the asso-
ciations, 253 publications were found in Portuguese (31.5%), 
521 (65.0%) and Spanish 28 (2.5%). These results prove that 
choosing to use keyword associations in all three languages 
was the best option.
The observation of the level of evidence of each study is im-
portant to establish the reliability of the results that will be used 
and, in this way, to strengthen the conclusions that will come 
from the research in development. The studies can be classified 
into seven levels of evidence, namely: Level I - systematic review 
or meta-analysis, coming from all relevant randomized con-
trolled clinical trials; Level II - randomized clinical trial; Level III 
- non-randomized clinical trial; Level IV - cohort or case-control 
studies; Level V - systematic review of descriptive and qualitative 
studies; Level VI - descriptive or qualitative study and Level VII 
- studies whose evidence comes from the opinion of authorities 
and / or report of expert committees(12). 
Socio-demographic and genotype aspects of study participants
The majority of respondents who participated in the sur-
veys had low levels of schooling. Studies in the US(5) and 
Cuba(27) have shown that patients with schooling aged 12 
years or more had higher HRQL scores.
Several authors have shown that low schooling can nega-
tively influence the evolution of chronic disease, due to the 
compromised ability to read and understand orientations dur-
ing health education actions(31-32), resulting in failure to adopt 
healthy behaviors and adherence to treatment and, conse-
quently, to lower QOL scores(33-36).
As for the marital situation, it was found that most of the 
participants denied being married or living marital with any-
one. Several studies have shown that married or companion 
patients had higher HRQL scores(5,22,28).
Women constituted the majority of the sample in 95.5% 
of the articles selected for this review. The FD is not a dis-
ease influenced by gender, however, women make more use 
of health services than men and are more likely to negatively 
assess their health status(23). 
It is believed that the demand for health services does 
not occur solely through necessity, but through different 
determinations that explain the variations between social 
groups, among them, the different social roles that men and 
women play in society and the way in which both express 
their disease(30). There were predominant forms of severe DF 
(HbSS or SβºTal) in 20 articles and, in two, the genotype was 
not reported. HbSS is the most prevalent genotype in Bra-
zil(3,19,22,25,28) and in the world(1-2,5,7,13,15,17,20,27) and is often as-
sociated with a lower life expectancy(37-38). 
Chart 2 – Distribution of adult patients with sickle cell disease according to health-related quality of life scores
 Patients who presented lower health-related quality of life scores Patients who presented higher health-related quality of life scores
− symptomatic (n = 1)(2)
− who had frequent painful crises (n = 9)(2,13-15-19,25,28)
− with severe form of the disease (n = 8)(1,2,13,16-18,26,28)
− with frequent hospitalizations (n = 1)(25)
− who needed blood transfusions (n = 2)(21,25)
− with comorbidities or complications imposed by the disease (n = 3)(17,20,25)
− with lower hemoglobin levels (n = 1)(2)
− who did not adhere to or with late onset of treatment (n = 1)(20)
− who declared themselves victims of prejudice due to the disease (n = 1)(3)
− with mood disorder (n = 1)(28)
− with double heterozygosity (HbSC) (n = 3)(1,17,26)
− with less severe forms of sickle cell disease (n = 3)(1,7,17)
− who lived in rural areas (n = 1)(1)
− married (n = 2)(5,28)
− women (n = 1)(5)
− employees (n = 3)(1,18,21)
− with income above $ 30,000 per year (n = 1)(5)
− with 12 years of schooling or more (n = 3)(5,18,21)
− under treatment with hydroxyurea (n = 1)(14)
− who received effective treatments for pain and depression (n = 1)(17)
− with early medical intervention and adherence to treatment (n = 1)(20)
− with regular physical activity (n = 1)(21)
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Quality of life of patients with sickle cell disease
In six studies, the patients interviewed reported several 
limitations with a decrease in QoL(16,20,23,26,28). FD is a chronic 
and therefore limiting disease, especially when it occurs in 
the most severe forms. Chronic diseases interfere with pa-
tients’ ability to perform their daily activities, which may lead 
to temporary or permanent disability, as well as irreversible 
damage to the functioning of various organs, causing work 
impediment and leading to a decrease in QoL(23). HbSS and 
Sβ-tal, more severe forms of FD, are associated with lower 
scores on QOL(2,13,16,26).
The main manifestation of DF is the painful crisis(16), caused 
by vaso-occlusion, due to the falcization of red blood cells. 
The pain is intense, abrupt onset and is the major cause of 
hospitalization. Many patients with frequent episodes of pain-
ful crises presented lower HRQoL scores and significant de-
crease of the score when their pain levels increased(13). Pain is 
considered the main cause of physical and emotional destabi-
lization of patients with DF(17).
Patients with complications caused by the disease (pain 
crises and those requiring opioids, hospitalizations, blood 
transfusions, among others) presented HRQL worse than the 
general population(2,13,15-21,25,28); neurobehavioral comorbidi-
ties (anxiety, attention or behavior problems, depression, de-
velopmental delay or mental retardation, sleep disturbances, 
learning difficulties, seizures or speech problems)(20); (history 
of stroke, acute chest syndrome, recurrent priapism, more 
than three hospitalizations due to vaso-occlusive crisis in the 
last three years, bone complications, clinical conditions re-
quiring transfusions and frequent hospitalizations)(17,19-20,25).
A study developed in the USA by Dampier et al., Showed 
that the number of complications increased substantially with 
age, but only a few (vaso-occlusive pain or opioid use) signifi-
cantly influenced the reduction of HRQoL in adults with FD. 
The researchers suggested that more effective treatments for 
persistent pain and depression would contribute to the better 
QoL of these patients(17).
The way each person perceives pain is unique, subjective, 
and unique. This perception is influenced by sensory, cogni-
tive, affective and socio-behavioral factors(39). 
In the research conducted by van Tuijn et al., in the Nether-
lands, it was possible to observe that the QOL scores in patients 
with FD appear to be determined mainly by the pain and so-
cial circumstances (occupation and educational level) and that, 
despite the contribution of cumulative organ damage, such as 
mild pulmonary hypertension on prognosis and life expectan-
cy, do not seem to be determinants of QOL in FD(16).
Patients with lower Hb(2), mood disorder, low schooling, low-
er income, single and non-adherent to treatment or who started 
late had also had lower HRQoL scores. On the other hand, pa-
tients with dual heterozygosity with less severe forms of FD who 
lived in a rural area, married, had a job, had high schooling(5) 
and practiced regular physical exercise, scored HRQOL better(21).
Research developed by Ahmed et al.(21) demonstrated that 
regular exercise tends to decrease pain and improve social 
function and vitality. This research suggested the importance 
of regular exercises in controlling the burden of disease 
through the development of physical training programs for 
people living with FD. However, the authors also reported 
that interventional studies are needed to evaluate the role of 
regular physical activity in the HRQoL of patients with FD.
It is observed that the interventions whose objectives are 
to adequately control pain in the crisis, improve vitality and 
mental health(17,28), prevent pain crises (such as the use of hy-
droxyurea)(14), early medical intervention and in encouraging 
treatment adherence(20) may contribute to the maintenance of 
high levels of QoL in patients with FD. 
Scales used to assess health-related quality of life
The majority (86.36%) of the articles selected used generic 
HRQoL scales. Generic instruments have the advantage of evaluat-
ing several areas or domains in diverse populations, which allows 
comparisons between patients with different diseases, but may be 
unable to demonstrate changes in some specific aspects(9,17).
In this review, it was observed that the most used HRQoL 
assessment scale was SF36 (n = 11). It is a generic, multidi-
mensional scale, consisting of 36 items, divided into eight do-
mains: Functional Capacity, Physical Aspects, Emotional As-
pects, Pain, General Health Status, Vitality, Social Aspects and 
Mental Health. It is one of the instruments most frequently 
used for HRQL measurements and has been adopted in sever-
al studies on chronic diseases for evaluating both the positive 
and negative aspects of the disease (1,4,13-14,16-17,21,23,26-28).
The WHOQOLBref scale, used in seven studies(3,15,19-20,22,24-25) 
selected for this review, is composed of 26 questions, the first 
of which concerns the individual perception of quality of life 
and the second, to the individual’s perception of health. The 
remaining 24 questions comprise four domains: Physical, 
Psychological, Social and Environmental. The EQ-5D, a scale 
used by one of the sample studies, was developed by the Eu-
roQoL group in the late 1980s. It allows the generation of an 
index representing the value of an individual’s health status. 
Its five dimensions are: mobility, personal care, usual activi-
ties, pain / malaise and anxiety / depression(18,40).
Three studies participating in the study discussed the de-
velopment of specific scales to evaluate the HRQoL of adults 
with FD: CEB-S(2), SIMS(5) and ASCQ-Me(7). The specific instru-
ments, usually also multidimensional, although they do not 
allow comparisons between patients with different patholo-
gies, are shown to be clinically more sensitive, since they are 
developed to evaluate in more detail the HRQoL of patients 
considering specific aspects of a certain disease(9,29). 
The CEB-S, created in Cuba, is composed of 30 issues, di-
vided into four domains: physical area, emotional area, social 
area and pain(2).
SIMS was developed by researchers at the University of Ten-
nessee, USA, and is composed of 142 multidimensional items. 
Each of them is inserted in one of four domains: pain, physical 
function, emotional well-being and social functioning(5).
Another specific scale found in this review was the ASCQ-
Me, also developed in the USA. It is a multidimensional ques-
tionnaire, composed of 92 items, divided into six sets of ques-
tions (domains): cognitive impact, emotional impact, sleep 
impact, social functioning, pain and stiffness(7).
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Limitations of the study
Although necessary, inclusion criteria may impose limi-
tations on the study. For this review, four databases (MED-
LINE, CUMED, LILACS and SciELO) were selected, which 
was a limiting factor, since the journals not indexed there 
were not selected for the sample. In addition, three studies 
were excluded because they were published in languages 
other than those set out in the inclusion criteria (Portuguese, 
English and Spanish).
Although the English language is used in most scientific 
studies, it is believed that research that includes other data-
bases and publications in other languages may contribute to 
broaden the findings of this review.
Contributions to the nursing area
It is hoped that this review may stimulate reflection and 
debate among nurses and other health professionals about the 
importance of assessing the quality of life of adult patients 
with sickle cell disease.
The knowledge of the HRQoL of these people makes it pos-
sible to subsidize the work of the health team with data rel-
evant to the elaboration of interventions, programs and health 
policies that aim to improve their QoL.
CONCLUSION
This review showed that the concern with QOL of adult pa-
tients with DF is not recent, but has been growing. It has also 
demonstrated that the disease has high morbidity and mor-
tality, with varied and intense clinical manifestations, which 
include pain, infections and multiple organ failure, which has 
an impact on patients’ QoL, which have worse HRQoL scores 
than the general population 
There are several factors that may negatively affect the HRQoL 
of adults with FD such as: intensity and frequency of painful cri-
ses, need for hospitalization and blood transfusion, non-adher-
ence to treatment or late onset, and social circumstances (marital 
status, unemployment , low schooling and low economic power).
Studies show that patients with FD who adhere to treatment 
and those in whom the intervention is early have better HRQL 
results. In addition, it is known that the lower HRQL scores were 
related to impaired functional capacity, physical limitations and 
limitations due to emotional aspects. Thus, it is believed that 
early intervention, with more effective treatments for persistent 
pain and depression, can bring great benefit in HRQoL.
Three articles portrayed the elaboration of specific scales 
to evaluate QOL of adults with FD; however, in this review, it 
was verified that none of them had been used in Brazilian pa-
tients, which evidenced the need to perform the transcultural 
translation and adaptation of these scales into Portuguese. 
This discovery motivated the lead author to initiate the pro-
cess of translation and cultural adaptation of the SIMS scale, 
with the consent of its developer group.
In light of the above, it was verified that HRQoL measures 
should be applied in all centers treating patients with DF in or-
der to subsidize nurses in the planning of their care, education 
and social interventions and in proposing strategies aimed at 
improving the QV of this clientele.
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